CAJ | 학술논문

目的：探讨131I治疗老年甲状腺功能亢进性心脏病的临床疗效。方法选择2010年3月~2014年4月我院收治的30例甲状腺功能亢进性心脏病患者,给予患者口服131I。且治疗前、治疗后3个月、6个月、1年行对甲状腺功能复查；治疗前、治疗后1年行门控心血池显像,以综合评价治疗效果。结果治疗1年后,27例甲状腺功能正常,2例好转,治愈率为96.7%；在治疗前、治疗后3个月、治疗后6个月以及治疗后1年,FT3、FT4水平逐渐降低,TSH水平逐渐升高,差异的具有统计学意义,<0.05；治疗1年后,患者在LVEF、1/3EF、PER、PFR、TPER上均有所改善,治疗前后差异具有统计学意义,<0.05。结论131I治疗老年甲亢性心脏病,可有效控制FT3、FT4、TSH水平,提高老年甲亢性心脏病患者心功能。
목적：탐토131I치료노년갑상선공능항진성심장병적림상료효。방법선택2010년3월~2014년4월아원수치적30례갑상선공능항진성심장병환자,급여환자구복131I。차치료전、치료후3개월、6개월、1년행대갑상선공능복사；치료전、치료후1년행문공심혈지현상,이종합평개치료효과。결과치료1년후,27례갑상선공능정상,2례호전,치유솔위96.7%；재치료전、치료후3개월、치료후6개월이급치료후1년,FT3、FT4수평축점강저,TSH수평축점승고,차이적구유통계학의의,<0.05；치료1년후,환자재LVEF、1/3EF、PER、PFR、TPER상균유소개선,치료전후차이구유통계학의의,<0.05。결론131I치료노년갑항성심장병,가유효공제FT3、FT4、TSH수평,제고노년갑항성심장병환자심공능。
Objective To study the 131 I in treatment of senile thyroid function hyperfunction of heart disease clinical curative ef ect. Methods In March 2010to April 2014 our hospital 30 cases of thyroid function hyperfunction sex heart disease patients, oral 131 I give patients. And before and after treatment for 3 months, 6 months, 1 year review of thyroid function; Before and after treatment 1 year line, the gated blood pool imaging in comprehensive evaluation of the ef icacy of treatment. Results 1 year after treatment, 27 cases of normal thyroid function, improved in 2 cases, cure rate is 96.7%;Before and after treatment for 3 months, 6 months after treatment and 1 year after treatment, FT3, FT4 level gradual y reduce, TSH level increased, statistical y significant dif erence, <0.05;, 1 year after treatment in patients with LVEF, 1/3 of ef, PER, (PFR), which improved TPER, statistical y significant dif erences before and after treatment, < 0.05). Conclusion 131 I in treatment of senile hyperthyroidism heart disease, which can ef ectively control the FT3, FT4, TSH level, improve heart function in elderly patients with hyperthyroidism sex heart disease.